PCMH
ELV icon

Polymer Capital Management (HK)’s Elevance Health ELV Stock Holding History

Polymer Capital Management (HK)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,387
Closed -$448K – 172
2025
Q3 		$448K Buy
+1,387
New +$431K 0.06% 142

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Polymer Capital Management (HK)'s ELV Position: Q4 2025 in Review

Polymer Capital Management (HK) sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,387 shares — an estimated $448K sold.

Polymer Capital Management (HK) first reported a position in ELV in Q3 2025 and held it in 1 quarter. The position peaked at $448K in Q3 2025. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Polymer Capital Management (HK) reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Polymer Capital Management (HK) sold 1,387 Elevance Health shares in Q4 2025, an estimated $448K.
  • Polymer Capital Management (HK) first reported a position in Elevance Health in Q3 2025 and held it in 1 quarter.
  • Polymer Capital Management (HK)'s Elevance Health position peaked at $448K in Q3 2025.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Polymer Capital Management (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.